98%
921
2 minutes
20
Ammonium perfluoro (2-methyl-3-oxahexanoate) (GenX) is one of short-chain alternatives of perfluorooctanoic acid (PFOA) and has emerged as persistent global environmental pollutant due to its resistance to degradation. Nonetheless, the effects and mechanisms of perinatal exposure to GenX or PFOA on both mothers and offspring enterohepatic system remain poorly understood. In this study, pregnant C57BL/6J mice were administered 1 mg/kg body weight (bw)/day of PFOA or 2 mg/kg bw/day of GenX until the fourth week postpartum, with or without an inulin intervention at 5 g/kg bw/day. The results indicated that GenX or PFOA exposure significantly induced liver injury, gut microbiota imbalance, and intestinal barrier damage in the dams, as well as caused liver function changes, increase in the intestinal permeability, and pyroptosis induction in the pups. Furthermore, inulin intervention mitigated intestinal toxicity in the pups by remodeling the gut microbiota composition in the dams and inhibiting the TLR4/NF-κB/NLRP3 inflammatory pathway in the pups. Taken together, this study elucidated that intestinal homeostasis imbalance induced by the perinatal GenX or PFOA exposure in the dams vertically mediated intestinal toxicity in the pups and highlighted the potential therapeutic role of inulin, contributing to a better understanding and management of environmental pollutant-induced health issue.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envpol.2025.126749 | DOI Listing |
Folia Microbiol (Praha)
September 2025
Department of Gastroenterology, Chongqing University Cancer Hospital, Chongqing, China.
Microbiome dysbiosis in reflux esophagitis has been extensively studied. However, limited research has examined microbiota across different segments of the upper gastrointestinal tract in reflux esophagitis. In this study, we investigated microbial alterations in three esophageal segments (upper, middle, and lower) and the gastric fundus of reflux esophagitis patients and healthy controls.
View Article and Find Full Text PDFNat Cancer
September 2025
Nature Cancer, .
J Immunother Cancer
September 2025
National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Background: Improving the efficacy of anti-programmed death 1 (PD-1) monoclonal antibody (mAb) therapy remains a major challenge for cancer immunotherapy in non-small cell lung cancer (NSCLC). Gut microbial metabolites can influence immunotherapy efficacy.
Methods: ELISA was used to compare the serum 5-hydroxyindoleacetic acid (5-HIAA) level in patients with NSCLC.
BMJ Open
September 2025
Department of Gastroenterology, Hepatology, Infectious Diseases and Intoxication, University Hospital Heidelberg, Heidelberg, Germany.
Introduction: Combined vascular endothelial growth factor/programmed death-ligand 1 blockade through atezolizumab/bevacizumab (A/B) is the current standard of care in advanced hepatocellular carcinoma (HCC). A/B substantially improved objective response rates compared with tyrosine kinase inhibitor sorafenib; however, a majority of patients will still not respond to A/B. Strong scientific rationale and emerging clinical data suggest that faecal microbiota transfer (FMT) may improve antitumour immune response on PD-(L)1 blockade.
View Article and Find Full Text PDFMicrob Pathog
September 2025
Department of Chinese Formulae, Heilongjiang University of Chinese Medicine, Harbin, China. Electronic address:
Sepsis is a systemic inflammatory response syndrome triggered by infection. Severe sepsis is associated with dysbiosis of the intestinal flora and impaired intestinal function. Ellagic acid (EA) is a natural compound known for its ability to inhibit bacteria and viruses, thereby preventing infections.
View Article and Find Full Text PDF